Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908.
Frasci G, D'Aiuto G, Comella P, D'Aiuto M, Di Bonito M, Ruffolo P, Iodice G, Petrillo A, Lastoria S, Oliviero P, Capasso I, Montella M, Siani C, Santangelo M, Vizioli L, Comella G; Southern Italy Cooperative Oncology Group (SICOG) Italy.
Frasci G, et al.
Ann Oncol. 2010 Apr;21(4):707-716. doi: 10.1093/annonc/mdp356. Epub 2009 Oct 8.
Ann Oncol. 2010.
PMID: 19815652
Clinical Trial.